Cargando…

Cocaine-induced granulomatosis with polyangiitis—an under-recognized condition

OBJECTIVES: Cocaine and cocaine mixed with levamisole are increasingly used in the UK and result in significant direct nasal damage in addition to promoting vasculitis. Our aims were as follows: (1) to identify the main symptoms and presentation of cocaine-induced vasculitis; (2) to provide evidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Gill, Charn, Sturman, Joseph, Ozbek, Leyla, Henderson, Scott R, Burns, Aine, Hamour, Sally, Pepper, Ruth J, McClelland, Lisha, Chanouzas, Dimitrios, Gane, Simon, Salama, Alan D, Harper, Lorraine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070056/
https://www.ncbi.nlm.nih.gov/pubmed/37026037
http://dx.doi.org/10.1093/rap/rkad027
_version_ 1785018960403496960
author Gill, Charn
Sturman, Joseph
Ozbek, Leyla
Henderson, Scott R
Burns, Aine
Hamour, Sally
Pepper, Ruth J
McClelland, Lisha
Chanouzas, Dimitrios
Gane, Simon
Salama, Alan D
Harper, Lorraine
author_facet Gill, Charn
Sturman, Joseph
Ozbek, Leyla
Henderson, Scott R
Burns, Aine
Hamour, Sally
Pepper, Ruth J
McClelland, Lisha
Chanouzas, Dimitrios
Gane, Simon
Salama, Alan D
Harper, Lorraine
author_sort Gill, Charn
collection PubMed
description OBJECTIVES: Cocaine and cocaine mixed with levamisole are increasingly used in the UK and result in significant direct nasal damage in addition to promoting vasculitis. Our aims were as follows: (1) to identify the main symptoms and presentation of cocaine-induced vasculitis; (2) to provide evidence regarding the best practice for the investigation and diagnosis of cocaine-induced vasculitis; and (3) to analyse the clinical outcomes of patients in order to understand the optimal management for the condition. METHODS: We performed a retrospective case series analysis of patients presenting with cocaine-induced midline destructive lesions or vasculitis compatible with granulomatosis with polyangiitis (GPA) from two large tertiary vasculitis clinics between 2016 and 2021. RESULTS: Forty-two patients (29 Birmingham, 13 London) with cocaine-induced midline lesions or systemic disease were identified. The median age was 41 years (range 23–66 years). Current cocaine use was common, and 20 of 23 samples provided were positive when routine urine toxicology was performed; 9 patients who denied ever using cocaine were identified as using cocaine based on urine toxicology analysis, and 11 who stated they were ex-users still tested positive. There was a high incidence of septal perforation (75%) and oronasal fistula (15%). Systemic manifestations were less common (27%), and only one patient had acute kidney injury. Fifty-six per cent of our patients were PR3-ANCA positive, with none testing positive for MPO-ANCA. Symptom remission required cocaine discontinuation even when immunosuppression was administered. CONCLUSION: Patients with destructive nasal lesions, especially young patients, should have urine toxicology performed for cocaine before diagnosing GPA and considering immunosuppressive therapy. The ANCA pattern is not specific for cocaine-induced midline destructive lesions. Treatment should be focused on cocaine cessation and conservative management in the first instance in the absence of organ-threatening disease.
format Online
Article
Text
id pubmed-10070056
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-100700562023-04-05 Cocaine-induced granulomatosis with polyangiitis—an under-recognized condition Gill, Charn Sturman, Joseph Ozbek, Leyla Henderson, Scott R Burns, Aine Hamour, Sally Pepper, Ruth J McClelland, Lisha Chanouzas, Dimitrios Gane, Simon Salama, Alan D Harper, Lorraine Rheumatol Adv Pract Original Article OBJECTIVES: Cocaine and cocaine mixed with levamisole are increasingly used in the UK and result in significant direct nasal damage in addition to promoting vasculitis. Our aims were as follows: (1) to identify the main symptoms and presentation of cocaine-induced vasculitis; (2) to provide evidence regarding the best practice for the investigation and diagnosis of cocaine-induced vasculitis; and (3) to analyse the clinical outcomes of patients in order to understand the optimal management for the condition. METHODS: We performed a retrospective case series analysis of patients presenting with cocaine-induced midline destructive lesions or vasculitis compatible with granulomatosis with polyangiitis (GPA) from two large tertiary vasculitis clinics between 2016 and 2021. RESULTS: Forty-two patients (29 Birmingham, 13 London) with cocaine-induced midline lesions or systemic disease were identified. The median age was 41 years (range 23–66 years). Current cocaine use was common, and 20 of 23 samples provided were positive when routine urine toxicology was performed; 9 patients who denied ever using cocaine were identified as using cocaine based on urine toxicology analysis, and 11 who stated they were ex-users still tested positive. There was a high incidence of septal perforation (75%) and oronasal fistula (15%). Systemic manifestations were less common (27%), and only one patient had acute kidney injury. Fifty-six per cent of our patients were PR3-ANCA positive, with none testing positive for MPO-ANCA. Symptom remission required cocaine discontinuation even when immunosuppression was administered. CONCLUSION: Patients with destructive nasal lesions, especially young patients, should have urine toxicology performed for cocaine before diagnosing GPA and considering immunosuppressive therapy. The ANCA pattern is not specific for cocaine-induced midline destructive lesions. Treatment should be focused on cocaine cessation and conservative management in the first instance in the absence of organ-threatening disease. Oxford University Press 2023-04-04 /pmc/articles/PMC10070056/ /pubmed/37026037 http://dx.doi.org/10.1093/rap/rkad027 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Gill, Charn
Sturman, Joseph
Ozbek, Leyla
Henderson, Scott R
Burns, Aine
Hamour, Sally
Pepper, Ruth J
McClelland, Lisha
Chanouzas, Dimitrios
Gane, Simon
Salama, Alan D
Harper, Lorraine
Cocaine-induced granulomatosis with polyangiitis—an under-recognized condition
title Cocaine-induced granulomatosis with polyangiitis—an under-recognized condition
title_full Cocaine-induced granulomatosis with polyangiitis—an under-recognized condition
title_fullStr Cocaine-induced granulomatosis with polyangiitis—an under-recognized condition
title_full_unstemmed Cocaine-induced granulomatosis with polyangiitis—an under-recognized condition
title_short Cocaine-induced granulomatosis with polyangiitis—an under-recognized condition
title_sort cocaine-induced granulomatosis with polyangiitis—an under-recognized condition
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070056/
https://www.ncbi.nlm.nih.gov/pubmed/37026037
http://dx.doi.org/10.1093/rap/rkad027
work_keys_str_mv AT gillcharn cocaineinducedgranulomatosiswithpolyangiitisanunderrecognizedcondition
AT sturmanjoseph cocaineinducedgranulomatosiswithpolyangiitisanunderrecognizedcondition
AT ozbekleyla cocaineinducedgranulomatosiswithpolyangiitisanunderrecognizedcondition
AT hendersonscottr cocaineinducedgranulomatosiswithpolyangiitisanunderrecognizedcondition
AT burnsaine cocaineinducedgranulomatosiswithpolyangiitisanunderrecognizedcondition
AT hamoursally cocaineinducedgranulomatosiswithpolyangiitisanunderrecognizedcondition
AT pepperruthj cocaineinducedgranulomatosiswithpolyangiitisanunderrecognizedcondition
AT mcclellandlisha cocaineinducedgranulomatosiswithpolyangiitisanunderrecognizedcondition
AT chanouzasdimitrios cocaineinducedgranulomatosiswithpolyangiitisanunderrecognizedcondition
AT ganesimon cocaineinducedgranulomatosiswithpolyangiitisanunderrecognizedcondition
AT salamaaland cocaineinducedgranulomatosiswithpolyangiitisanunderrecognizedcondition
AT harperlorraine cocaineinducedgranulomatosiswithpolyangiitisanunderrecognizedcondition